The Ridgways’s decision was not unusual. Among pregnant women in the United States who receive a Down syndrome diagnosis, ...

Jesse Ridgway and Ashley terminated their pregnancy after a Down syndrome diagnosis, igniting a fierce national debate. The ...

Millions of women could soon have greater access to GLP-1 weight loss medications following the global effort to change the name of a hormonal condition that affects 1 in 8 women globally. The ...

Insulin resistance can develop for years without a single noticeable symptom — and by the time it does show up, the path ...

Internet stars Jesse Ridgway, 33, and Ashley Ridgway, 31, announced they had made the 'difficult decision' to terminate their ...

ResMed (RMD) outlines growth catalysts in sleep & breathing health: AI, wearables, GLP-1 tailwinds, COPD, and Noctrix RLS deal—read key takeaways now.

ResMed Inc. (RMD) 46th Annual William Blair Growth Stock Conference June 2, 2026 5:40 PM EDTCompany ParticipantsMichael Farrell - CEO ...

As weight loss medications containing active ingredients like semaglutide continue to define a new chapter in metabolic ...

Dr. Jaclyn Smeaton, ND   A clinical review of the landmark renaming of PCOS to PMOS and why this shift reframes the condition ...

Athens-Limestone Hospital introduces the FDA-approved Genio system to North Alabama, offering innovative nerve stimulation ...

Athens-Limestone Hospital is is expanding its sleep treatment options with the addition of a therapy that can serve as an alternative to CPAP devices for moderate to severe sleep apnea […] ...

Athens-Limestone Hospital is marking a new milestone in sleep surgery, highlighting expanded access to advanced treatment ...